Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel T Lehrer

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical Sciences|September 15, 2020
Preservation of Quaternary Structure in Thermostable, Lyophilized Filovirus Glycoprotein Vaccines: A Search for Stability-Indicating AssaysKendall B Preston, Connor R Monticello, Teri Ann S Wong, et al.
Plos Neglected Tropical Diseases|August 24, 2019
A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infectionsJasmine Tyson, Wen-Yang Tsai, Jih-Jin Tsai, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
CoVaccine HT™ adjuvant potentiates robust immune responses to recombinant SARS-CoV-2 Spike S1 immunisationBrien K Haun, Chih-Yun Lai, Caitlin A Williams, et al.
Frontiers in Immunology|November 16, 2020
CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 ImmunizationBrien K Haun, Chih-Yun Lai, Caitlin A Williams, et al.
Molecular Pharmaceutics|November 30, 2022
Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory InfectionsDaiqin Chen, Xin Yun, Daiheon Lee, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 PrecursorsRyan Bailey, Kalista Kahoekapu, Albert To, et al.
Vaccines|January 28, 2026
Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 PrecursorsRyan Bailey, Kalista Kahoekapu, Albert To, et al.
Immuno|April 17, 2025
High-Avidity Anti-Filovirus IgG Elicited Using Protein Subunit Vaccines Does Not Correlate with ProtectionCaitlin A Williams, Teri Ann S Wong, Michael M Lieberman, et al.
Vaccine|February 21, 2017
Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in miceAxel T Lehrer, Teri-Ann S Wong, Michael M Lieberman, et al.
Msphere|January 24, 2018
Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in MiceAlbert To, Liana O Medina, Kenji O Mfuh, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|September 15, 2020
Preservation of Quaternary Structure in Thermostable, Lyophilized Filovirus Glycoprotein Vaccines: A Search for Stability-Indicating AssaysKendall B Preston, Connor R Monticello, Teri Ann S Wong, et al.
Plos Neglected Tropical Diseases|August 24, 2019
A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infectionsJasmine Tyson, Wen-Yang Tsai, Jih-Jin Tsai, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
CoVaccine HT™ adjuvant potentiates robust immune responses to recombinant SARS-CoV-2 Spike S1 immunisationBrien K Haun, Chih-Yun Lai, Caitlin A Williams, et al.
Frontiers in Immunology|November 16, 2020
CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 ImmunizationBrien K Haun, Chih-Yun Lai, Caitlin A Williams, et al.
Molecular Pharmaceutics|November 30, 2022
Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory InfectionsDaiqin Chen, Xin Yun, Daiheon Lee, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 PrecursorsRyan Bailey, Kalista Kahoekapu, Albert To, et al.
Vaccines|January 28, 2026
Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 PrecursorsRyan Bailey, Kalista Kahoekapu, Albert To, et al.
Immuno|April 17, 2025
High-Avidity Anti-Filovirus IgG Elicited Using Protein Subunit Vaccines Does Not Correlate with ProtectionCaitlin A Williams, Teri Ann S Wong, Michael M Lieberman, et al.
Vaccine|February 21, 2017
Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in miceAxel T Lehrer, Teri-Ann S Wong, Michael M Lieberman, et al.
Msphere|January 24, 2018
Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in MiceAlbert To, Liana O Medina, Kenji O Mfuh, et al.
Pageof 4